Cryomed Aesthetics has expanded its professional portfolio with the appointment as exclusive distributor of Mesoestetic professional skincare across Australia and New Zealand, effective 1 January, 2026.
The partnership brings one of Europe’s most established professional skincare brands into Cryomed’s growing distribution network, reinforcing the company’s focus on evidence-based, clinic-only solutions supported by structured education and protocol-driven use. Mesoestetic is internationally recognised for its work in pigment management and cosmeceutical formulations designed for integration with in-clinic procedures. The brand’s portfolio includes professional peels, homecare products and targeted systems addressing conditions including melasma, dyschromia, acne and photoageing.
As the officially appointed distributor, Cryomed will be the trusted source for authentic Mesoestetic products across Australia and New Zealand. Clinics will have access to the full product warranty, certified education programs and approved treatment protocols, along with marketing materials and consumer-focused resources.
The partnership will also deliver timely access to product updates, global innovations and newly released lines, supported by ongoing clinical and commercial expertise from Cryomed’s experienced team.
‘This partnership marks an important step forward for the professional aesthetics market in Australia and New Zealand,’ said Brent van den Berg, Head of Cryomed.
‘Mesoestetic’s global reputation for science-led innovation aligns strongly with our focus on clinical excellence. Together, we are focused on equipping clinics with advanced technologies, deeper education, and solutions that drive real-world results.’
A seamless and supported transition for clinics
Mesoestetic has confirmed that its investment in Australia and New Zealand remains strong, with the new distribution model focused on elevating clinical excellence and customer experience. Under Cryomed’s stewardship, clinics can expect a confident and carefully managed transition into 2026.
Key benefits of the new partnership include a dedicated Cryomed team supporting the Mesoestetic brand, access to an expanded professional and retail portfolio, and a renewed focus on education, training, and support for treatment protocols. Clinics will also benefit from enhanced clinical integration, marketing and business development resources, and innovation aligned with Mesoestetic’s global priorities.
The addition of Mesoestetic follows what has been a period of significant growth for Cryomed Aesthetics. In October 2024, the company became the exclusive distributor of Cynosure Lutronic technologies, consolidating its position in the energy-based device space. More recently, Cryomed also added Sofwave to its portfolio, further strengthening its offering in non-invasive aesthetic treatments.
Together, these appointments reflect Cryomed’s strategy of building a tightly curated portfolio that spans devices, consumables and skincare, with an emphasis on long-term clinical partnerships. The inclusion of Mesoestetic broadens the company’s reach within professional skincare, creating new opportunities for integrated treatment planning across devices and topical protocols.
As Cryomed continues to expand its footprint in the Australian and New Zealand aesthetic markets, the Mesoestetic appointment marks another step in the company’s evolution as a multi-category distributor supporting advanced, practitioner-led aesthetic care.
For more information contact Cryomed Aesthetics on 1300 346 448 or visit www.cryomed.com.au.
